Artificial Kidney

AWAK Technologies raised $40 million to continue development of its wearable peritoneal dialysis device, which has received a breakthrough designation from the FDA.

In a recently published article, researchers provided an overview of ambulatory hemodialysis devices, which they suggest “offer the potential for self-care treatment outside the clinical setting as well as frequent and prolonged sessions.” However, they argued that ongoing efforts related to technological improvements and safety are required before implementation.

Continuing the focus on artificial kidney development put forth by the current administration’s plan to treat kidney disease, The American Society of Nephrology’s Kidney Health Initiative has produced two resources for both patients and innovators.